Semaglutide News

Novo Nordisk Explores Wegovy Combination And Wider Semaglutide Benefits As Shares Fall - Yahoo Finance

Novo Nordisk Explores Wegovy Combination And Wider Semaglutide Benefits As Shares Fall Yahoo Finance

Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics - Fortune

Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics Fortune

ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes - Fierce Pharma

ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes Fierce Pharma

Novo Nordisk broadens semaglutide case beyond weight loss - The Pharma Letter

Novo Nordisk broadens semaglutide case beyond weight loss The Pharma Letter

Popular weight loss drug may slow down biological aging: Study - NewsNation

Popular weight loss drug may slow down biological aging: Study NewsNation

One Weight Loss Strategy Is 5x More Effective Than Ozempic, Study Shows - ScienceAlert

One Weight Loss Strategy Is 5x More Effective Than Ozempic, Study Shows ScienceAlert

AI scans 400,000 Reddit posts and finds hidden Ozempic side effects - ScienceDaily

AI scans 400,000 Reddit posts and finds hidden Ozempic side effects ScienceDaily

Canadians eye generic Ozempic as the drug hits the market hundreds of dollars cheaper - CBC

Canadians eye generic Ozempic as the drug hits the market hundreds of dollars cheaper CBC

FDA moves to remove GLP-1 medications from 503B Bulks List - Medical News Today

FDA moves to remove GLP-1 medications from 503B Bulks List Medical News Today

Study: Popular GLP-1 Drug May Slow Down Biological Aging - UC San Diego Today

Study: Popular GLP-1 Drug May Slow Down Biological Aging UC San Diego Today

Ecnoglutide Delivers 35% Greater Weight Loss Than Semaglutide in Head-to-Head Trial - HCPLive

Ecnoglutide Delivers 35% Greater Weight Loss Than Semaglutide in Head-to-Head Trial HCPLive

The Frontier of Metabolic Health: High-Dose Oral Semaglutide Redefines Diabetes and Obesity Care - Pharmacy Times

The Frontier of Metabolic Health: High-Dose Oral Semaglutide Redefines Diabetes and Obesity Care Pharmacy Times

Ecnoglutide Shows Greater Weight Loss Than Semaglutide in Trial - The Clinical Trial Vanguard

Ecnoglutide Shows Greater Weight Loss Than Semaglutide in Trial The Clinical Trial Vanguard

Tirzepatide vs Semaglutide For Weight Loss: What’s The Difference? - Forbes

Tirzepatide vs Semaglutide For Weight Loss: What’s The Difference? Forbes

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes - AJMC

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes AJMC

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data - PR Newswire

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data PR Newswire

Semaglutide Linked to Quality-of-Life Gains in CKD - Docwire News

Semaglutide Linked to Quality-of-Life Gains in CKD Docwire News

CSPC PHARMA (01093.HK) Semaglutide Long-acting Injection Approved in US for Clinical Trials - AASTOCKS.com

CSPC PHARMA (01093.HK) Semaglutide Long-acting Injection Approved in US for Clinical Trials AASTOCKS.com

Why Canadians can now get cheaper generic Ozempic - and Americans can't - BBC

Why Canadians can now get cheaper generic Ozempic - and Americans can't BBC

CagriSema beats semaglutide on weight loss, HbA1c in type 2 diabetes trials - The Clinical Trial Vanguard

CagriSema beats semaglutide on weight loss, HbA1c in type 2 diabetes trials The Clinical Trial Vanguard

Retatrutide vs. Semaglutide for Weight Loss—What’s the Difference? - Forbes

Retatrutide vs. Semaglutide for Weight Loss—What’s the Difference? Forbes

High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes - HCPLive

High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes HCPLive

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications - PR Newswire

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications PR Newswire

ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D - Pharmacy Times

ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D Pharmacy Times

CagriSema Outperforms Semaglutide Alone Across Phase 3 REIMAGINE Trials - HCPLive

CagriSema Outperforms Semaglutide Alone Across Phase 3 REIMAGINE Trials HCPLive

Semaglutide 7.2 mg Shows Greater BMI, Cardiometabolic Gains in T2D - HCPLive

Semaglutide 7.2 mg Shows Greater BMI, Cardiometabolic Gains in T2D HCPLive

Microdosing Semaglutide: Does It Work for Weight Loss? - Cedars-Sinai

Microdosing Semaglutide: Does It Work for Weight Loss? Cedars-Sinai

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial - Nature

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Nature

Semaglutide Boosts Quality of Life in T2D and CKD, FLOW Trial Analysis Finds - Patient Care Online

Semaglutide Boosts Quality of Life in T2D and CKD, FLOW Trial Analysis Finds Patient Care Online

Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons - Nature

Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons Nature

GLP-1 RAs Effective for Weight Loss in Rheumatic and Musculoskeletal Diseases - Rheumatology Advisor

GLP-1 RAs Effective for Weight Loss in Rheumatic and Musculoskeletal Diseases Rheumatology Advisor

Inventage Lab presents ADA data on long-acting semaglutide, tirzepatide obesity therapies - koreabiomed.com

Inventage Lab presents ADA data on long-acting semaglutide, tirzepatide obesity therapies koreabiomed.com

Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide - Pharmacy Times

Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide Pharmacy Times

ADA: Novo's Wegovy pill reaches new GLP-1 patients with impressive 3M prescription milestone - Fierce Pharma

ADA: Novo's Wegovy pill reaches new GLP-1 patients with impressive 3M prescription milestone Fierce Pharma

CSPC PHARMA (01093.HK) Semaglutide Long-acting Injection Approved in US for Clinical Trials - AASTOCKS.com

CSPC PHARMA (01093.HK) Semaglutide Long-acting Injection Approved in US for Clinical Trials AASTOCKS.com

FLOW Analysis: Semaglutide Delivers Consistent Kidney Benefit in T2D/CKD Across CVD Status - American College of Cardiology

FLOW Analysis: Semaglutide Delivers Consistent Kidney Benefit in T2D/CKD Across CVD Status American College of Cardiology